Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and BeyondAlistair Mathie, Paul D. Wright, Emma L. Veale et al.|The Annual Review of Pharmacology and Toxicology|2020Cited by 73
Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3Paul D. Wright, Jeffrey C. Jerman, Emma L. Veale et al.|Biochemical and Biophysical Research Communications|2017Cited by 38
Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2Paul D. Wright, Alistair Mathie, David McCoull et al.|Biochemical and Biophysical Research Communications|2019Cited by 21
A “Target Class” Screen to Identify Activators of Two-Pore Domain Potassium (K2P) ChannelsDavid McCoull, Paul D. Wright, Emma Ococks et al.|SLAS DISCOVERY|2020Cited by 10
Aprepitant is a novel, selective activator of the K2P channel TRAAKDavid McCoull, Paul D. Wright, Emma L. Veale et al.|Biochemical and Biophysical Research Communications|2021Cited by 8